Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priyankar Dey

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
British Journal of Pharmacology|December 7, 2020
Low bioavailability hinders drug discovery against COVID-19, guided by in silico dockingPriyankar Dey
Frontiers in Immunology|November 17, 2025
Genes, guts, and microbes: decoding host-driven microbial regulation using intestine-specific conditional knockoutsPriyankar Dey
Frontiers in Nutrition|October 10, 2025
Gut microbial signatures associated with the Indian lean MASLD phenotypePriyankar Dey
Nutrients|October 16, 2025
All That Glitters Ain't Gold: The Myths and Scientific Realities About the Gut MicrobiotaPriyankar Dey
Microbial Pathogenesis|March 16, 2024
Good girl goes bad: Understanding how gut commensals cause diseasePriyankar Dey
Pharmacological Research|August 20, 2020
Targeting gut barrier dysfunction with phytotherapies: Effective strategy against chronic diseasesPriyankar Dey
Life Sciences|August 2, 2020
The role of gut microbiome in chemical-induced metabolic and toxicological murine disease modelsPriyankar Dey
Hepatology (Baltimore, Md.)|February 10, 2019
Letter to Editor: Carbon Tetrachloride-Induced Classical Liver Cirrhosis Model: Revisiting the Mode of ActionPriyankar Dey
Frontiers in Endocrinology|November 5, 2025
The emerging phenotype of nonalcoholic fatty liver disease in lean individuals: what's different?Priyankar Dey
Phytotherapy Research : PTR|January 4, 2023
Gut microbial considerations and feasibility of phytochemicals as anti-COVID prophylaxis: Critical role of bioavailabilityPriyankar Dey
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
British Journal of Pharmacology|December 7, 2020
Low bioavailability hinders drug discovery against COVID-19, guided by in silico dockingPriyankar Dey
Frontiers in Immunology|November 17, 2025
Genes, guts, and microbes: decoding host-driven microbial regulation using intestine-specific conditional knockoutsPriyankar Dey
Frontiers in Nutrition|October 10, 2025
Gut microbial signatures associated with the Indian lean MASLD phenotypePriyankar Dey
Nutrients|October 16, 2025
All That Glitters Ain't Gold: The Myths and Scientific Realities About the Gut MicrobiotaPriyankar Dey
Microbial Pathogenesis|March 16, 2024
Good girl goes bad: Understanding how gut commensals cause diseasePriyankar Dey
Pharmacological Research|August 20, 2020
Targeting gut barrier dysfunction with phytotherapies: Effective strategy against chronic diseasesPriyankar Dey
Life Sciences|August 2, 2020
The role of gut microbiome in chemical-induced metabolic and toxicological murine disease modelsPriyankar Dey
Hepatology (Baltimore, Md.)|February 10, 2019
Letter to Editor: Carbon Tetrachloride-Induced Classical Liver Cirrhosis Model: Revisiting the Mode of ActionPriyankar Dey
Frontiers in Endocrinology|November 5, 2025
The emerging phenotype of nonalcoholic fatty liver disease in lean individuals: what's different?Priyankar Dey
Phytotherapy Research : PTR|January 4, 2023
Gut microbial considerations and feasibility of phytochemicals as anti-COVID prophylaxis: Critical role of bioavailabilityPriyankar Dey
Pageof 8